Article
An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.
Molecular cancer - 8 Sept 2021
Ramírez-Moya Julia, Miliotis Christos, Baker Allison R, Gregory Richard I, Slack Frank J, Santisteban Pilar
Abstract excerpt
BACKGROUND: Adenosine deaminases acting on RNA (ADARs) modify many cellular RNAs by catalyzing the conversion of adenosine to inosine (A-to-I), and their deregulation is associated with several cancers. We recently showed that A-to-I editing is elevated in thyroid tumors and that ADAR1 is functionally important for thyroid cancer cell progression. The downstream effectors regulated or edited by ADAR1 and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
